sof_logo

Palabras de Condolencia

 On April 21, 2003, Dr. Ogita died at a young age of 55. As the developer of OK-432 therapy, savior of many patients of lymphatic malformations, and great contributor to the world to pioneer the new treatment, Dr. Ogita held the faith that "efforts are to be done in order to make results of my research available to all the patients."